• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    71 Biggest Movers From Yesterday

    5/20/22 4:27:31 AM ET
    $ACRX
    $AFI
    $APCX
    $AUUD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Building Products
    Capital Goods
    Get the next $ACRX alert in real time by email

    Gainers

    • NeuroMetrix, Inc. (NASDAQ:NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.
    • VivoPower International PLC (NASDAQ:VVPR) gained 46.3% to close at $1.58.
    • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) surged 29.6% to close at $0.7905. The FDA recently reviewed NeuroOne Medical Technologies appeal for 510(k) clearance for its Evo sEEG Electrode for less than 30-day use.
    • BIT Mining Limited (NYSE:BTCM) rose 28.1% to settle at $2.10.
    • Pop Culture Group Co., Ltd (NASDAQ:CPOP) gained 27.6% to close at $1.11. Pop Culture recently posted Q1 sales of $20.15 million.
    • AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) surged 27.6% to settle at $0.2892. The FDA has recently modified the AcelRx Pharmaceuticals Dsuvia Risk Evaluation and Mitigation Strategies (REMS) requirements for healthcare setting audits.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) jumped 25.4% to close at $1.63.
    • Celyad Oncology SA (NASDAQ:CYAD) gained 25% to close at $1.9250.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) jumped 25% to settle at $13.60.
    • Pineapple Energy Inc. (NASDAQ:PEGY) gained 24.2% to close at $2.72.
    • Grab Holdings Limited (NASDAQ:GRAB) rose 24.1% to settle at $3.14 after reporting Q1 results.
    • IMAC Holdings, Inc. (NASDAQ:IMAC) gained 22.3% to close at $1.04. IMAC Holdings’ 13G Filing from Notable Investor Peter Lynch showed a new 5.23% stake in the company.
    • Applied Blockchain, Inc. (NASDAQ:APLD) jumped 21.7% to close at $3.09.
    • Chimerix, Inc. (NASDAQ:CMRX) gained 21.6% to close at $2.20. Emergent BioSolutions recently agreed to acquire Chimerix exclusive worldwide rights to Tembexa (brincidofovir), the first FDA-approved antiviral for all age groups for smallpox.
    • Austin Gold Corp. (NYSE:AUST) rose 21.1% to settle at $2.07.
    • Troika Media Group, Inc. (NASDAQ:TRKA) gained 20.9% to close at $0.6990.
    • NanoViricides, Inc. (NYSE:NNVC) surged 20.9% to close at $1.85.
    • Iris Energy Limited (NYSE:IREN) gained 20.4% to close at $6.74.
    • Cellectis S.A. (NASDAQ:CLLS) surged 20.2% to close at $3.93.
    • AppTech Payments Corp. (NASDAQ:APCX) gained 20% to settle at $0.7657.
    • Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) rose 18.9% to close at $0.3491. Eloxx Pharmaceuticals recently reported quarterly losses of $0.13 per share.
    • Biotricity, Inc. (NASDAQ:BTCY) gained 18.8% to settle at $1.33.
    • Indaptus Therapeutics, Inc. (NASDAQ:INDP) surged 18.8% to settle at $2.97. The U.S. Food and Drug Administration (FDA) has announced clearance to Indaptus Therapeutics’ Investigational New Drug (IND) application for a Phase 1 clinical trial of its drug candidate Decoy20 in patients with advanced solid tumors where currently approved therapies have failed.
    • Staffing 360 Solutions, Inc. (NASDAQ:STAF) jumped 18.1% to close at $0.7523.
    • Immunome, Inc. (NASDAQ:IMNM) climbed 18% to close at $3.35 after the company published data demonstrating its COVID-19 antibody cocktail IMM-BCP-01 cleared the omicron variant of SARS-CoV-2 when tested in vivo in hamsters.
    • Zealand Pharma A/S (NASDAQ:ZEAL) climbed 17.9% to close at $13.79 after the company announced the results from its phase 3 trial of Dasiglucagon in pediatric patients with congenital hyperinsulinism met the primary endpoint with statistical significance.
    • Eve Holding, Inc. (NYSE:EVEX) surged 17.7% to close at $8.35.
    • Nano-X Imaging Ltd. (NASDAQ:NNOX) gained 17.7% to close at $11.12. Nanox reported Q1 earnings results.
    • SIGA Technologies, Inc. (NASDAQ:SIGA) shares rose 17.1% to close at $8.65 after the company announced the FDA approved the intravenous formulation of TPOXX for the treatment of smallpox.
    • Aclarion, Inc. (NASDAQ:ACON) gained 16.7% to close at $1.75.
    • Snow Lake Resources Ltd. (NASDAQ:LITM) climbed 16.5% to close at $3.81 after the company reported results from its first drill tests from the Grass River Pegmatite dyke. The company also said its exploration permits have been extended by the Province of Manitoba for 3 years.
    • Sprout Social, Inc. (NASDAQ:SPT) rose 16.1% to close at $48.07.
    • Sweetgreen, Inc. (NYSE:SG) climbed 15.9% to close at $22.23.
    • GDS Holdings Limited (NASDAQ:GDS) climbed 14.5% to settle at $31.09. GDS Holdings posted a Q1 net loss of $58.9 million.
    • Bill.com Holdings, Inc. (NASDAQ:BILL) rose 12.6% to close at $114.42.
    • Novan, Inc. (NASDAQ:NOVN) gained 12.3% to settle at $2.92. Novan will present Berdazimer Gel, 10.3% (SB206) clinical data at Annual Meeting of the Society for Investigative Dermatology.
    • Kodiak Sciences Inc. (NASDAQ:KOD) rose 11.8% to settle at $6.71 after company director Felix Baker reported the purchase of 456,690 shares at an average price of $5.91 per share in a Form 4 filing on Wednesday.
    • Emergent BioSolutions Inc. (NYSE:EBS) rose 11.8% to close at $31.69.
    • Humanigen, Inc. (NASDAQ:HGEN) gained 10.3% to close at $2.24. Humanigen recently posted Q1 loss of $0.32 per share.
    • Synopsys, Inc. (NASDAQ:SNPS) surged 10.3% to close at $300.52 after the company reported better-than-expected Q2 results. The company also issued Q3 and FY22 EPS and sales guidance above analyst estimates.
    • Unity Software Inc. (NYSE:U) rose 10.2% to close at $41.65.
    • Chinook Therapeutics, Inc. (NASDAQ:KDNY) rose 10% to close at $13.85 as the company announced updated interim results from the Phase 1/2 study of BION-1301 in IgA nephropathy (IgAN).
    • Datadog, Inc. (NASDAQ:DDOG) rose 9.6% to close at $96.53.
    • Blend Labs, Inc. (NYSE:BLND) rose 6.7% to close at $3.53.

     

    Losers

    • Bright Green Corporation (NASDAQ:BGXX) shares tumbled 67.4% to close at $15.70 on Thursday after jumping 90% on Wednesday. Bright Green, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to list on a major U.S. stock exchange.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) fell 39% to close at $3.05 on Thursday.
    • Molecular Data Inc. (NASDAQ:MKD) dipped 27.5% to close at $0.1007. Molecular Data said on May 17 it received delinquency compliance plan alert letter from NASDAQ.
    • Prenetics Holding Company Limited (NASDAQ:PRE) fell 26.4% to close at $5.63.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) fell 21.4% to close at $0.2548. Enjoy Technology recently reported worse-than-expected Q1 EPS and sales results.
    • Triumph Group, Inc. (NYSE:TGI) tumbled 20.4% to settle at $14.25 as Baird lowered the price target on the stock from $36 to $26. Triumph Group, on Wednesday, reported worse-than-expected Q4 EPS and sales results.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) fell 17.9% to close at $5.25.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) fell 17.4% to close at $1.90. China SXT Pharmaceuticals reported a 1 for 20 reverse share split.
    • Auddia Inc. (NASDAQ:AUUD) declined 17.1% to settle at $0.9293.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) dropped 16.9% to close at $1.18.
    • Under Armour, Inc. (NYSE:UA) fell 15.8% to close at $8.18 after Morgan Stanley and Williams Capital downgraded the stock. Under Armour announced Wednesday that CEO Patrik Frisk is stepping down from his role of CEO, president and as a member of the Board of Directors.
    • TScan Therapeutics, Inc. (NASDAQ:TCRX) declined 14.8% to close at $3.05.
    • Mercurity Fintech Holding Inc. (NYSE:MFH) dropped 14.7% to close at $1.22.
    • Decisionpoint Systems, Inc. (NYSE:DPSI) fell 14.4% to close at $6.98.
    • Kidpik Corp. (NASDAQ:PIK) dropped 14.1% to close at $1.89.
    • Cisco Systems, Inc. (NASDAQ:CSCO) dipped 13.7% to close at $41.72. Cisco reported upbeat earnings for its third quarter, while sales missed estimates. The company also issued weak Q4 and FY22 earnings guidance.
    • Tenaya Therapeutics, Inc. (NASDAQ:TNYA) fell 13.4% to close at $5.62.
    • View, Inc. (NASDAQ:VIEW) dropped 13.1% to close at $0.6494.
    • Armstrong Flooring, Inc. (NYSE:AFI) fell 11.9% to close at $0.3787. Armstrong Flooring shares jumped 46% on Wednesday after receiving approval for additional financing.
    • OTR Acquisition Corp. (NASDAQ:OTRA) fell 11.8% to close at $9.91.
    • Conifer Holdings, Inc. (NASDAQ:CNFR) declined 11.4% to settle at $1.48.
    • Fresh Vine Wine, Inc. (NYSE:VINE) dipped 10.8% to close at $3.05. Fresh Vine Wine recently posted a Q1 loss of $0.35 per share.
    • Harley-Davidson, Inc. (NYSE:HOG) dropped 9.3% to close at $32.43. Harley-Davidson said certain vehicle assembly, shipments suspended for 2-week period, excluding livewire production.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) fell 9.1% to close at $0.1972 after climbing over 20% on Wednesday. Salarius Pharmaceuticals recently posted a Q1 loss of $0.13 per share.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) fell 8.9% to close at $2.78 after gaining around 7% on Wednesday.
    • Monro, Inc. (NASDAQ:MNRO) fell 8.8% to close at $39.80 as the company posted Q4 results and announced a $150 million buyback. American Tire Distributors announced plans to acquire Monro's Tires Now distribution assets for $105 million in cash.
    • Bath & Body Works, Inc. (NYSE:BBWI) fell 6.8% to close at $40.03 after the company cut its FY22 EPS guidance below analyst estimates.
    Get the next $ACRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACRX
    $AFI
    $APCX
    $AUUD

    CompanyDatePrice TargetRatingAnalyst
    Synopsys Inc.
    $SNPS
    2/27/2026$480.00Overweight → Equal-Weight
    Morgan Stanley
    Sprout Social Inc
    $SPT
    2/27/2026$9.00Buy → Hold
    Canaccord Genuity
    Eos Energy Enterprises Inc.
    $EOSE
    2/27/2026$20.00Buy → Neutral
    Guggenheim
    Bath & Body Works Inc.
    $BBWI
    2/27/2026$17.00 → $23.00Market Perform
    Telsey Advisory Group
    Synopsys Inc.
    $SNPS
    2/20/2026$455.00Buy → Hold
    HSBC Securities
    Cisco Systems Inc.
    $CSCO
    2/18/2026Buy → Hold
    Erste Group
    Bath & Body Works Inc.
    $BBWI
    2/17/2026$25.00Buy → Neutral
    Citigroup
    Cellectis S.A.
    $CLLS
    2/17/2026$7.00Buy
    Jefferies
    More analyst ratings

    $ACRX
    $AFI
    $APCX
    $AUUD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Synopsys downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Synopsys from Overweight to Equal-Weight and set a new price target of $480.00

    2/27/26 8:29:50 AM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    Sprout Social downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Sprout Social from Buy to Hold and set a new price target of $9.00

    2/27/26 8:29:50 AM ET
    $SPT
    Computer Software: Prepackaged Software
    Technology

    Eos Energy downgraded by Guggenheim with a new price target

    Guggenheim downgraded Eos Energy from Buy to Neutral and set a new price target of $20.00

    2/27/26 8:28:11 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    $ACRX
    $AFI
    $APCX
    $AUUD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Derosa Thomas Joseph bought $6,754 worth of shares (20,000 units at $0.34), increasing direct ownership by 77% to 46,096 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    2/27/26 6:16:02 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Director Lord Albert L bought $51,040 worth of shares (150,000 units at $0.34), increasing direct ownership by 5% to 3,170,394 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    2/26/26 5:35:56 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Director Lord Albert L bought $1,665 worth of shares (4,200 units at $0.40), increasing direct ownership by 0.14% to 3,020,394 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    2/17/26 7:22:57 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    $ACRX
    $AFI
    $APCX
    $AUUD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Derosa Thomas Joseph bought $6,754 worth of shares (20,000 units at $0.34), increasing direct ownership by 77% to 46,096 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    2/27/26 6:16:02 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    SVP, Chief Financial Officer Yahes Jarrod sold $220,382 worth of shares (12,196 units at $18.07), decreasing direct ownership by 2% to 533,933 units (SEC Form 4)

    4 - Unity Software Inc. (0001810806) (Issuer)

    2/27/26 5:29:17 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    Chief Accounting Officer Barrysmith Mark sold $191,144 worth of shares (10,578 units at $18.07), decreasing direct ownership by 3% to 383,901 units (SEC Form 4)

    4 - Unity Software Inc. (0001810806) (Issuer)

    2/27/26 5:24:37 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    $ACRX
    $AFI
    $APCX
    $AUUD
    SEC Filings

    View All

    SEC Form PRE 14A filed by NeuroOne Medical Technologies Corporation

    PRE 14A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)

    2/27/26 4:31:17 PM ET
    $NMTC
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Sprout Social Inc

    S-8 - Sprout Social, Inc. (0001517375) (Filer)

    2/27/26 4:08:51 PM ET
    $SPT
    Computer Software: Prepackaged Software
    Technology

    Indaptus Therapeutics Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Financial Statements and Exhibits

    8-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)

    2/27/26 4:05:49 PM ET
    $INDP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRX
    $AFI
    $APCX
    $AUUD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Presurance Holdings Announces Closing of Rights Offering

    TROY, Mich., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Presurance Holdings, Inc. (NASDAQ:PRHI) ("Presurance" or the "Company") today announced the closing of its rights offering (the "Rights Offering"), previously detailed in the Company's Current Report on Form 8-K filed on January 28, 2026. Pursuant to the terms of the Rights Offering, 4,284,640 shares of the Company's common stock, no par value (the "Common Stock"), were purchased upon the exercise of the subscription rights at the subscription price of $1.00 per share of Common Stock at the closing of the Rights Offering on February 27, 2026 (the "Closing"). Pursuant to the Rights Offering Backstop Agreement, dated as of February 3, 2026, by

    2/27/26 1:20:22 PM ET
    $CNFR
    $PRHI
    Property-Casualty Insurers
    Finance

    Bath & Body Works Hops Into Spring With Joy-Filled PEEPS® Collaboration

     What to know:  Bath & Body Works is launching a limited-time PEEPS® collaboration for spring and Easter. The joyful, nostalgia-driven collection brings the iconic Marshmallow treat to life across body care, home fragrance, décor and accessories. The collection features a marshmallow gourmand fragrance, Peepin' It Real. Developed with world-class perfumers, the scent blends fluffy marshmallow, sugar crystals and whipped vanilla to deliver a true-to-life, crave-worthy fragrance experience inspired by PEEPS®. The collection will be available to Bath & Body Works loyalty members online beginning Sunday, March 1, and to all consumers Monday, March 2 in stores and online across the U.S. and Cana

    2/27/26 9:00:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ACRX
    $AFI
    $APCX
    $AUUD
    Leadership Updates

    Live Leadership Updates

    View All

    Synopsys Appoints Former Deloitte Executive Peter Shimer to Board of Directors and Announces Board Transitions

    SUNNYVALE, Calif., Feb. 19, 2026 /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced the appointment of Peter A. Shimer to its board of directors. Shimer brings four decades of experience at international public accounting firm Deloitte where he held numerous executive roles, including serving as its interim chief executive officer (CEO). During his tenure on the Deloitte executive committee and under his financial stewardship, the firm increased annual revenue by more than 135% to $30 billion. Shimer's appointment is effective immediately, and he will serve on the board's audit committee.

    2/19/26 4:01:00 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    IREN Appoints John Gross as Chief Innovation Officer

    NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ:IREN) ("IREN") today announced the appointment of John Gross as Chief Innovation Officer, a newly established role responsible for leading engineering standards, thermal architecture, and commissioning across IREN's next-generation data centers. Mr. Gross is a globally recognized leader in data center engineering, with two decades of industry experience and deep expertise in high-density and liquid-cooled data center design. He serves as Vice Chair of committees within ASHRAE (American Society of Heating, Refrigerating and Air-Conditioning Engineers), which develops global standards for high-density and liquid-cooled data ce

    2/17/26 5:00:50 AM ET
    $IREN
    EDP Services
    Technology

    Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

    Ollie Bearman becomes the latest elite athlete to invest in NASDAQ:PRE, underscoring a deep belief in the brand's mission and products.IM8, co-founded by David Beckham, continues to attract top-tier athletes who prioritize scientifically validated and trusted nutritional support.IM8 has become one of the fastest-growing supplement brands globally, achieving an extraordinary US$100 million in Annual Recurring Revenue in just 11 months from launch.Bearman's rapid rise – including a historic points-scoring Ferrari debut at just 18—cements his reputation as one of motorsport's brightest young talents. NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE), a leading

    2/13/26 8:00:00 AM ET
    $PRE
    Blank Checks
    Finance

    $ACRX
    $AFI
    $APCX
    $AUUD
    Financials

    Live finance-specific insights

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Sweetgreen, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

    Sweetgreen, Inc. (NYSE:SG) (the "Company"), the mission-driven, next-generation restaurant and lifestyle brand that serves healthy food at scale, today announced financial results for its fourth fiscal quarter and fiscal year ended December 28, 2025. Fourth Quarter 2025 Financial Highlights For the fourth quarter of fiscal year 2025, compared to the fourth quarter of fiscal year 2024: Total revenue decreased 3.5% to $155.2 million. Same-Store Sales Change of (11.5)%, versus 4.4%. Total Digital Revenue Percentage of 65.1%, up from 56.0% and Owned Digital Revenue Percentage(1) of 38.0%, up from 29.2%. Loss from operations was $(48.1) million and loss from operations margin was

    2/26/26 4:05:00 PM ET
    $SG
    Restaurants
    Consumer Discretionary

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRX
    $AFI
    $APCX
    $AUUD
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRX
    $AFI
    $APCX
    $AUUD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by Indaptus Therapeutics Inc.

    SC 13D/A - Indaptus Therapeutics, Inc. (0001857044) (Subject)

    11/26/24 4:11:08 PM ET
    $INDP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by NeuroOne Medical Technologies Corporation

    SC 13G/A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Subject)

    11/26/24 8:42:10 AM ET
    $NMTC
    Medical/Dental Instruments
    Health Care